Profit Distribution and Financial Performance - The profit distribution plan for 2024 proposes a cash dividend of RMB 3.40 per 10 shares, totaling approximately RMB 282.55 million, which accounts for 79.57% of the net profit attributable to ordinary shareholders[6]. - The total cash dividend distribution is based on the total share capital eligible for profit distribution on the record date[6]. - The company reported a total of 29,653,334 shares at the beginning of the year, with a decrease to 11,861,333 shares by year-end, resulting in a net change of 41,514,667 shares due to capital reserve conversion[171]. - The company plans to implement a three-year shareholder dividend return plan from 2024 to 2026, which was approved during the shareholders' meeting[170]. - The company has a cash dividend policy that stipulates a minimum of 10% of the distributable profit must be distributed as cash dividends each year[196]. - In the case of a mature company without significant capital expenditure plans, the minimum cash dividend proportion should be at least 80% of the profit distribution[197]. - The company is currently in a growth phase and plans to maintain a minimum cash dividend proportion of 20% in profit distribution due to significant future capital expenditures[197]. Audit and Governance - The company has received a standard unqualified audit report from its accounting firm, ensuring the accuracy and completeness of the financial report[5]. - The board of directors and management have collectively ensured the authenticity and integrity of the annual report[5]. - The company has established a robust governance structure to ensure compliance with legal requirements and protect shareholder rights, particularly for minority shareholders[168]. - The company actively participates in training programs for its board members and executives to enhance governance knowledge and decision-making capabilities[169]. - The board of directors must consider the opinions of independent directors and minority shareholders when making decisions on cash dividends[199]. - The company has established a remuneration policy that aligns with industry standards and regional economic conditions[181]. Revenue and Profit Trends - In 2024, the company achieved revenue of 6.67 billion RMB, a year-on-year increase of 2.59%[33]. - The net profit attributable to shareholders was 355.11 million RMB, a decrease of 45.76% compared to the previous year[34]. - The gross profit margin for the main business was 25.80%, down 5.65 percentage points year-on-year[34]. - The company's operating revenue for the reporting period was approximately ¥6.67 billion, representing a 2.59% increase compared to the previous year[106]. - Operating costs increased by 11.04% to approximately ¥4.94 billion, indicating rising expenses in service delivery[106]. - The company reported a significant increase in revenue, achieving a total of 1.5 billion yuan for the fiscal year, representing a 20% year-over-year growth[176]. Cash Flow and Financial Management - The company's cash flow from operating activities improved significantly, reaching 1.25 billion RMB, a 538.70% increase year-on-year[22]. - The net cash flow from operating activities surged by 538.70% to approximately ¥1.25 billion, reflecting improved operational efficiency[106]. - The net cash flow from operating activities for 2024 is ¥1,249,135,076.93, representing a 538.70% increase compared to ¥195,575,184.80 in 2023[122]. - The company has implemented a performance assessment system that includes cash flow metrics to enhance the efficiency of cash collection[108]. - The net cash flow from investment activities is -¥17,284,481.90, a decrease from -¥35,884,295.96 in the previous year[123]. - The net cash flow from financing activities is -¥352,641,573.61, compared to -¥181,223,989.67 in the previous year[123]. Business Segments and Market Performance - Revenue from the insurance IT sector decreased by 15.31% to 3.05 billion RMB, while non-insurance IT revenue increased, particularly in non-insurance finance, government, and healthcare sectors[33]. - Non-insurance finance IT revenue grew by 32.43% to 685 million RMB, government IT revenue increased by 20.38% to 1.29 billion RMB, and healthcare IT revenue rose by 37.31% to 408 million RMB[33]. - The software business revenue was 4.99 billion RMB, a decline of 5.14% year-on-year, with a gross margin of 29.53%, down 6.10 percentage points[33]. - The company is actively participating in large-scale domestic transformation projects for major clients such as Postal Savings Bank and Bank of China[47]. - The company aims to enhance customer coverage and optimize product structure in the non-insurance financial sector[47]. - The company is expanding its market presence, targeting a 25% increase in market share within the next two years[176]. Research and Development - R&D expenditure amounted to 908 million yuan, accounting for 13.60% of the current period's revenue, with a year-on-year decrease of 3.72%[62]. - The company is investing 200 million RMB in R&D for new technologies aimed at enhancing software capabilities[174]. - The number of R&D personnel is 5,927, accounting for 32.79% of the total workforce[119]. - The company aims to maintain a high level of product technology competitiveness through R&D innovation and intelligent solution upgrades[63]. - The company is investing heavily in R&D, allocating 10% of its revenue towards developing new technologies and products[176]. Strategic Initiatives and Future Outlook - The company aims to strengthen management and increase business investment to achieve a recovery in operating performance and high-quality development in 2025[39]. - The company will continue to expand its international strategy, targeting new customer acquisition and existing customer demand outside the mainland, aiming for rapid growth in international business[155]. - The overall business goal for 2025 is to achieve steady revenue growth while enhancing the proportion of high-tech businesses and improving business development quality[156]. - The company aims to capitalize on increasing investments in public health and medical information technology to accelerate growth in its healthcare IT business[78]. - The company is actively pursuing new customer acquisition and market expansion in Central Asia and Africa[60]. - The company will prioritize domestic replacement opportunities for key application software, particularly in the insurance sector, in light of the implementation of new accounting standards (IFRS17)[158]. Risks and Challenges - The company faces potential risks from cyclical fluctuations in IT investments from downstream industries, which may exert pressure on operations during certain phases[162][163]. - The competitive landscape in the software and IT services industry is intensifying, with increasing demand for new technologies and products, posing risks from new entrants[164]. - There is a shortage of composite talents who possess both technical skills and industry experience, which may impact the company's ability to meet client needs effectively[165]. Shareholder and Management Structure - The total remuneration for all directors, supervisors, and senior management at the end of the reporting period was 1,561.61 million yuan, including annual performance compensation and benefits[181]. - The independent director remuneration standard for 2024 is set at 120,000 yuan per year (pre-tax)[181]. - Non-independent directors receive a remuneration standard of 24,000 yuan per year (pre-tax)[181]. - The company has a performance-based compensation system for senior management, which includes "basic salary + performance pay" determined by the board based on company performance and industry standards[181]. - The company has made significant changes in shareholding, with the chairman's shares decreasing from 5,765,760 to 2,306,304, reflecting a change of 8,072,064 shares due to capital reserve conversion[171].

中科软（603927）公告，2025年第一季度营收为12.35亿元，同比下降4.08%；净亏损1623.67万元，去 年同期净利润2587.84万元。 ...

[Table_MainInfo] 公司研究/信息服务 证券研究报告 股本摊薄） 数据来源：Wind，公司公告，HTI 中科软（603927）公司年报点评 [Table_InvestInfo] 非保险 IT 增速亮眼， AIGC 应用多场景落地 [Table_Summary] 投资要点： 主要财务数据及预测 | [Table_FinanceInfo] 财务摘要（百万 | 2023A | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 元） 营业收入 | 6,503 | 6,671 | 7,233 | 7,866 | 8,520 | | (+/-)% | -3.0% | 2.6% | 8.4% | 8.8% | 8.3% | | 净利润（归母） | 655 | 355 | 383 | 505 | 658 | | (+/-)% | 2.6% | -45.8% | 7.9% | 31.7% | 30.3% | | 每股净收益（元） | 0.79 | 0.43 | 0.46 | 0.61 | 0.79 | | 净资产收益率( ...

登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603927证券简称：中科软 公告编号：2025-016 中科软科技股份有限公司 中科软科技股份有限公司（以下简称"公司"）已于2025年04月12日披露公司2024年年度报告，并将于 2025年04月25日披露公司2025年第一季度报告，为便于广大投资者更全面深入地了解公司2024年度及 2025年第一季度经营成果、财务状况，公司计划于2025年04月25日下午13:00-14:30举行2024年度暨2025 年第一季度业绩说明会，就投资者关心的问题进行交流。 一、业绩说明会类型 本次业绩说明会以视频结合网络互动形式召开，公司将针对2024年度及2025年第一季度经营成果及财务 指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行 回答。 三、参加人员 公司董事长、总经理左春先生，副总经理、财务总监张志华先生，独立董事何召滨先生、董事会秘书蔡 宏先生、证券部经理郧文龙先生、财务部经理杨培兰女士及公司其他相关人员（如有特殊情况，参会人 员将可能进行调整）。 四、投资者参加方式 （一）投资者可在2025年04月25 ...

证券代码：603927 证券简称：中科软 公告编号：2025-016 中科软科技股份有限公司 关于召开 2024 年度暨 2025 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性 陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、业绩说明会类型 本次业绩说明会以视频结合网络互动形式召开，公司将针对2024 年度及 2025 年第一季度经营成果及财务指标的具体情况与投资者进 会议召开时间：2025 年 04 月 25 日（星期五）下午 13:00-14:30 会议召开地点：上海证券交易所上证路演中心（网址： https://roadshow.sseinfo.com/） 会议召开方式：上证路演中心视频直播和网络互动 投资者可于 2025 年 04 月 18 日（星期五）至 04 月 24 日（星 期四）16:00 前登录上证路演中心网站首页，点击"提问预征集"栏 目或通过公司邮箱 sinosoftzqb@sinosoft.com.cn 进行提问。公司将 在业绩说明会上对投资者普遍关注的问题进行回答。 中科软科技股份有限公司（以下简称 ...

2025年4月12日，中科软(603927.SH)发布2024年年度报告。截至2025年4月11日，共有187个机构投资者 披露持有中科软A股股份，合计持股量达3.57亿股，占中科软总股本的42.96%。其中，前十大机构投资 者包括北京科软创源软件技术有限公司、北京市海淀区国有资本运营有限公司、北京市海淀区国有资产 投资经营有限公司、全国社保基金一一一组合、中国农业银行股份有限公司-中证500交易型开放式指数 证券投资基金、香港中央结算有限公司、华宝中证金融科技主题ETF、天弘中证500指数增强A、嘉实中 证软件服务ETF、华夏中证500ETF，前十大机构投资者合计持股比例达41.25%。相较于上一季度，前 十大机构持股比例合计下跌了0.44个百分点。 公募基金方面，本期较上一期持股增加的公募基金共计3个，包括华宝中证金融科技主题ETF、博时金 融科技ETF、华夏中证金融科技主题ETF，持股增加占比达0.61%。本期较上一季度持股减少的公募基 金共计1个，即南方中证500ETF，持股减少占比达0.23%。本期较上一季度新披露的公募基金共计178 个，主要包括天弘中证500指数增强A、嘉实中证软件服务ETF、华 ...

单Q4 来看，公司实现营收25.47 亿元，同比-1.36%，实现归母净利润0.65 亿元，同比-77.05%，略微承 压。单Q4 经营性现金流达20.01 亿元，同比增长55.04%。 深化AI 应用，持续投入AI 研发 公司继续将 AIGC 垂直应用作为重点研发方向，基于MaaS（ModelasaService）平台进行更多 AIGC 垂 直应用实践，包括举办内部技术交流、基于MaaS 平台推出 AIGC 在垂直领域的新应用、与生态伙伴合 作进行联合方案的研发等活动与成果。 2025 年一季度，中科软分别与华为、神州鲲泰等厂家合作，先后推出针对医疗卫生、保险等垂直领域 的 AIGC 应用联合方案。 公司于2025 年4 月11 日发布2024 年年报 全年营收稳中有增，非保险IT 版图扩张有效 公司全年实现营收66.71 亿元，同比2.59%，实现归母净利润3.55 亿元，同比-45.76%。全年毛利率达 25.93%，销售/管理/研发费用率分别为4.80%/1.46%/13.60%，同比变化-0.22/-0.17/-0.9 pct。费用整体有 效控制。全年经营性现金流为12.49 亿，同比增长538.7 ...

业绩简评 2025 年 4 月 11 日公司披露年报，实现营收 66.71 亿元，同比增长 2.6%；实现归母净利润 3.55 亿元，同比下降 45.8%；实现扣非归 母净利润 3.46 亿元，同比下降 46.3%。 经营分析 非保险行业收入占比提升，集成业务增加拖累毛利率。24 年公司 保险 IT 收入 30.47 亿元，同比下降 15.3%，系保险行业深化转型， 部分客户 IT 投入出现阶段性调整所致；24 年非保险金融 IT/政务 IT/医疗卫生 IT 分别实现营收 6.85/12.86/4.08 亿元，分别同比 增长 32.4%/20.4%/37.3%。分业务类型看，由于公司承接的部分大 银行客户系统集成项目验收确认收入，系统集成业务收入 16.67 亿元，同比增长 35.7%，导致公司主营业务毛利率同比下降 5.7pct 至 25.8%。 公司加强控费和现金流管理。公司员工人数同比下降 3.1%，24 年 销售/管理/研发费用率为 4.8%/1.5%/13.6%，分别同比下降 0.2pct/0.2pct/0.9pct。公司进一步优化合同条款、加强现金流 管理考核，全年销售商品、提供劳务收到的现金 8 ...

2025年4月11日，中科软（603927）发布了2024年年报。报告显示，公司全年实现营业总收入66.71亿 元，同比增长2.59%；归属净利润3.55亿元，同比大幅下降45.76%；扣非净利润3.46亿元，同比下降 46.34%。尽管公司在非保险金融、政务、医疗卫生等领域取得了一定增长，但保险IT业务的疲软成为 拖累整体业绩的主要因素。 保险IT业务大幅下滑，毛利率承压 2024年，中科软的保险IT业务收入为30.47亿元，同比下降15.31%，毛利率也从去年的35.69%下降至 27.47%。这一下滑主要源于保险行业客户IT投入的阶段性调整，部分客户基于"降本增效"压缩IT支出， 导致公司在该领域的收入和利润率双双下降。保险IT业务作为中科软的核心业务之一，其疲软表现直接 影响了公司整体毛利率，报告期内公司主营业务毛利率为25.80%，较去年同期下降5.65个百分点。 尽管公司在保险领域的客户覆盖率高达98%，核心业务系统覆盖率也达到82%，但行业整体IT预算的缩 减使得公司难以通过传统业务维持增长。此外，保险行业的复杂性和技术密集性使得AIGC技术的应用 成为未来发展的关键，但短期内尚未能弥补业务下滑 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 经公司第八届董事会第十次会议审议通过，2024年度利润分配预案为： 公司代码：603927 公司简称：中科软 第一节 重要提示 1、本年度报告摘要来自年度报告全文，为全面了解本公司的经营成果、财务状况及未来发展规划，投 资者应当到www.sse.com.cn网站仔细阅读年度报告全文。 2、本公司董事会、监事会及董事、监事、高级管理人员保证年度报告内容的真实性、准确性、完整 性，不存在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 3、公司全体董事出席董事会会议。 4、致同会计师事务所（特殊普通合伙）为本公司出具了标准无保留意见的审计报告。 5、董事会决议通过的本报告期利润分配预案或公积金转增股本预案 2、报告期公司主要业务简介 （1）报告期内公司所处行业情况 2024年我国软件和信息技术服务行业（以下简称"软件业"）继续保持稳中向好的发展态势，软件业务收 入实现平稳增长，利润总额增速小幅回落。2024年软件业务收入合计137276亿元，同比增长10%，利润 总额达16953亿元，同比提升8.7%，行业整体呈现出良性向上发展的势头。软件业务出口增长 ...